← Back to Insights
May 13, 2021
Authors
David W. Johnson Erika Haanpaa
Topics
COVID-19 Innovation Outcomes
Channels
Interviews Podcasts

Cain Brothers House Calls Podcast: Stigma vs. Science

Stigma vs. Science: Overcoming Opioid Addiction with Evidence-based Treatments and Services

Though the COVID pandemic dominated headlines, substance abuse and opioid-related deaths spiked dramatically in 2020. Cain Brothers’ Director Erika Haanpaa talks with host David Johnson, CEO of 4sight Health, about the distinct challenges of opioid addiction and new treatments and services creating hope for a better future. Cain Brothers is a division of KeyBanc Capital Markets.

Listen to this episode on Apple Podcasts, Spotify, and Google Podcasts.  

Read the related commentary here

About the Authors

David W. Johnson

David Johnson is the CEO of 4sight Health, an advisory company working at the intersection of healthcare strategy, economics, innovation. Johnson is a healthcare thought leader, keynote speaker, and strategic advisor to organizations busting the status-quo to reform our healthcare system. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, and his second book, The Customer Revolution in Healthcare: Delivering Kinder, Smarter, Affordable Care for All (McGraw-Hill 2019). As a speaker, Dave plays the role of rebel, challenger, industry historian, investor and company evaluator to push audiences forward. (Watch bio video.) Johnson applies his 25+ years of investment banking in healthcare to identify ways the healthcare industry must change to deliver better care. He received a Masters in Public Policy from Harvard Kennedy School, an English degree from Colgate University, and served in the African Peace Corp service. Join over 10k+ healthcare executives who read our weekly insights and commentary on www.4sighthealth.com. His third book, Less Healthcare, More Health: The Prescription for a Happier, More Equitable and Productive America, will publish in 2024.

Erika Haanpaa

Erika Haanpaa is a Director in the Firm’s Corporate M&A Advisory practice. Ms. Haanpaa joined Cain Brothers in 2018 and brings 10 years of investment banking and advisory experience, working with both private and public companies in a variety of merger and acquisition, capital raising, and capital markets transactions. Prior to joining Cain Brothers, Ms. Haanpaa was a Vice President in the Consumer and Retail Investment Banking Group at KeyBanc Capital Markets. Ms. Haanpaa’s prior experience also includes transaction advisory in KeyBanc Capital Markets’ Mergers and Acquisitions and Real Estate Investment Banking Groups. Ms. Haanpaa received her BS in Management from Purdue University and her MBA from the Kelley School of Business at Indiana University.

Recent Posts

Outcomes
Podcast Playlist: GLP-1 Drugs
Credit where it’s due: 4sight Health’s Julie Murchinson predicted the popularity of GLP-1 drugs long before the mainstream… Read More
By June 18, 2024
Innovation
Podcast: How Healthcare Revolutionaries Think with Bruce Brandes
Podcast: Bruce Brandes on Being an ‘Entrepreneur in Residence’ Bruce Brandes has learned a lot along his journey… Read More
By June 13, 2024
Default Image
Innovation
4sight Friday | May 31, 2024
4sight Friday | Behold the Market Magic of GLP-1 Drugs | The Broken Link Between Heart Disease and… Read More
By May 31, 2024